FDA greenlights new obesity treatment
The US Food and Drug Administration has granted approval for the Zepbound (tirzepatide) injection, a groundbreaking injection leading to weight loss. Tirzepatide, the active ingredient in Zepbound, is already approved under the trade name Mounjaro to be used along with diet and exercise to help improve blood sugar (glucose) in adults with type 2 diabetes […]
Continue Reading